ESR1 and early-onset autosomal dominant Alzheimer disease: Genetic alterations in the estrogen metabolic pathway have been reported to be associated with risk of Alzheimer’s Disease in a study of a southern Chinese population52 and association of ESR1 with one-year cognitive decline in healthy oldest-old individuals has also been cited53.